Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4063
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Roberts, P. | en |
dc.contributor.author | Lawley, C. | en |
dc.contributor.author | Tanous, D. | en |
dc.contributor.author | Anderson, B. | en |
dc.contributor.author | Celermajer, D. | en |
dc.contributor.author | Wilson, W. | en |
dc.contributor.author | Shipton, S. | en |
dc.contributor.author | O'Donnell, C. | en |
dc.date.accessioned | 2022-11-07T23:48:55Z | - |
dc.date.available | 2022-11-07T23:48:55Z | - |
dc.date.issued | 2019 | en |
dc.identifier.citation | 28 , 2019, p. S351-S352 | en |
dc.identifier.other | RIS | en |
dc.identifier.uri | http://dora.health.qld.gov.au/qldresearchjspui/handle/1/4063 | - |
dc.description.abstract | Background: The ANZ population undergoing PPVI, including short to medium term outcomes, has not been fully characterised. In particular, there are concerns about infective endocarditis (IE) risk. Methods: A multi-site retrospective cohort study across seven centres in ANZ. PPVI cases were identified using institutional databases and relevant details collected. Key outcomes evaluated at follow-up included mortality, morbidity (repeat procedure, infective endocarditis) and echocardiographic data. Results: From June 2009-March 2018, 134 individuals underwent PPVI utilising 123 Medtronic Melody™ valves and 11 Edwards SAPIEN valves (median age 18 years, range 9–60 years; median weight 59 kg, range 24–137 kg). Common underlying diagnoses were tetralogy of Fallot (n = 44, 33%) and pulmonary atresia +/- ventricular septal defect (n = 26, 19%). The most common previously employed conduit was a homograft (n = 91, 67%). Indications for PPVI included conduit stenosis (n = 75, 56%), regurgitation (n = 12, 9%) or mixed disease (n = 47, 35%). Immediate haemodynamic outcome was good; the peak stenotic gradient decreased from mean 40 mmHg to mean 11 mmHg (p = 0.047). Risk of severe procedural complication was low. There was one early post procedural death; due to device embolisation within the RVOT. In follow-up (median 21 months, range 0–98 months), there were two further deaths, unrelated to PPVI. Thirteen individuals developed IE (annualised incidence rate 4.6% per patient-year), 9 of these individuals required valve re-replacement. Two further individuals underwent valve replacement without IE. Conclusions: PPVI as performed in selected ANZ centres provides a relatively safe and feasible method of rehabilitating the RVOT.L20022345342019-08-01 <br /> | en |
dc.language.iso | en | en |
dc.relation.ispartof | Heart Lung and Circulation | en |
dc.title | Percutaneous Pulmonary Valve Implantation (PPVI) in Australia and New Zealand (ANZ) | en |
dc.type | Article | en |
dc.identifier.doi | 10.1016/j.hlc.2019.06.507 | en |
dc.subject.keywords | major clinical study | en |
dc.subject.keywords | male | en |
dc.subject.keywords | morbidity | en |
dc.subject.keywords | mortality | en |
dc.subject.keywords | multicenter study | en |
dc.subject.keywords | pulmonary valve atresia | en |
dc.subject.keywords | repeat procedure | en |
dc.subject.keywords | retrospective study | en |
dc.subject.keywords | stenosis | en |
dc.subject.keywords | percutaneous aortic valve | en |
dc.subject.keywords | adolescentadult | en |
dc.subject.keywords | adverse device effect | en |
dc.subject.keywords | allograft | en |
dc.subject.keywords | Australia and New Zealand | en |
dc.subject.keywords | bacterial endocarditis | en |
dc.subject.keywords | child | en |
dc.subject.keywords | clinical assessment | en |
dc.subject.keywords | cohort analysis | en |
dc.subject.keywords | complication | en |
dc.subject.keywords | conference abstract | en |
dc.subject.keywords | controlled study | en |
dc.subject.keywords | death | en |
dc.subject.keywords | device embolization | en |
dc.subject.keywords | Fallot tetralogy | en |
dc.subject.keywords | female | en |
dc.subject.keywords | follow up | en |
dc.subject.keywords | heart valve replacement | en |
dc.subject.keywords | heart ventricle septum defect | en |
dc.subject.keywords | hemodynamics | en |
dc.subject.keywords | human | en |
dc.relation.url | https://www.embase.com/search/results?subaction=viewrecord&id=L2002234534&from=exporthttp://dx.doi.org/10.1016/j.hlc.2019.06.507 | | en |
dc.identifier.risid | 2533 | en |
dc.description.pages | S351-S352 | en |
item.grantfulltext | none | - |
item.openairetype | Article | - |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
Appears in Sites: | Children's Health Queensland Publications |
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.